OptimizeRx Corporation (OPRX)
OPRX moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How OPRX actually reacts to news — the realized, point-in-time move the market made, measured across 276 labeled events over the last three years with zero look-ahead.
OPRX’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 38% | 272 |
| 30-min | 0.00% | 46% | 276 |
| 60-min | +0.12% | 51% | 276 |
| to close | 0.00% | 47% | 274 |
| Middle 50% of OPRX reactions | -1.23% to +0.98% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 276 |
Half of all OptimizeRx Corporation news events land between -1.23% and +0.98% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How OPRX reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 10 | +0.95% | 90% | -2.34% |
| Rating reiterations | 55 | -0.17% | 44% | -0.49% |
| Price-target raises | 10 | -0.18% | 50% | -0.41% |
| Price-target cuts | 12 | -1.34% | 33% | -0.98% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how OPRX ranks against every other measured name →
That’s how OPRX usually reacts — get an email when it moves on news →Email me when OPRX moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to OPRX's baseline. Nothing else.
Recent OPRX events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath | Press release | GlobeNewswire | -1.45% | +0.26% | |
| OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence | Press release | GlobeNewswire | +2.75% | +7.43% | |
| OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference | Press release | GlobeNewswire | -3.00% | -3.06% | |
| OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor | Press release | GlobeNewswire | -0.63% | +1.39% | |
| Form S-8 OptimizeRx Corp | SEC filing · Form S-8 | SEC EDGAR | +0.87% | -4.22% | |
| Form 10-Q OptimizeRx Corp For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.97% | +0.00% | |
| Form 8-K OptimizeRx Corp For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +8.50% | +28.74% | |
| OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth | Press release | GlobeNewswire | +8.50% | +28.74% | |
| OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance | Press release | GlobeNewswire | +8.50% | +28.74% | |
| OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET | Press release | GlobeNewswire | +1.42% | +0.47% | |
| OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer | Press release | GlobeNewswire | -1.41% | -2.97% | |
| OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent | Press release | GlobeNewswire | -2.04% | +5.93% | |
| OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms | Press release | GlobeNewswire | +1.67% | +2.08% | |
| Form 8-K OptimizeRx Corp For: Jun 09 | SEC filing · Form 8-K | SEC EDGAR | +2.10% | +1.53% | |
| Form 8-K OptimizeRx Corp For: Jun 01 | SEC filing · Form 8-K | SEC EDGAR | +0.19% | -1.94% | |
| Form DEFA14A OptimizeRx Corp | SEC filing · Form DEFA14A | SEC EDGAR | +0.29% | +3.46% | |
| OptimizeRx to Participate in Upcoming Investor Conferences | Press release | GlobeNewswire | +0.29% | +3.46% | |
| DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network | Press release | GlobeNewswire | -1.22% | +0.41% | |
| Form 10-Q OptimizeRx Corp For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.79% | +2.37% | |
| Form 8-K OptimizeRx Corp For: May 12 | SEC filing · Form 8-K | SEC EDGAR | -10.49% | -14.07% | |
| OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance | Press release | GlobeNewswire | -10.49% | -14.07% | |
| OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale | Press release | GlobeNewswire | +1.73% | -2.36% | |
| Form ARS OptimizeRx Corp For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.41% | +0.81% | |
| Form DEF 14A OptimizeRx Corp For: Jun 09 | SEC filing · Form DEF | SEC EDGAR | +0.41% | +0.81% | |
| OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report | Press release | GlobeNewswire | +0.41% | +0.81% | |
| OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Form 8-K OptimizeRx Corp For: Apr 03 | SEC filing · Form 8-K | SEC EDGAR | -1.10% | -2.99% | |
| OptimizeRx Appoints Mary Varghese Presti to Board of Directors | Press release | GlobeNewswire | -1.10% | -2.99% | |
| Form 8-K OptimizeRx Corp For: Mar 24 | SEC filing · Form 8-K | SEC EDGAR | -0.69% | -3.68% | |
| Form 10-K OptimizeRx Corp For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.33% | +6.49% | |
| Form 8-K OptimizeRx Corp For: Mar 05 | SEC filing · Form 8-K | SEC EDGAR | -13.83% | -2.88% | |
| OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | -13.83% | -2.88% | |
| UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results | Press release | GlobeNewswire | -13.83% | -2.88% | |
| OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET | Press release | GlobeNewswire | -1.15% | -3.21% | |
| OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing | Press release | GlobeNewswire | -1.16% | +3.59% | |
| OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network | Press release | GlobeNewswire | +1.28% | +1.47% | |
| Form 10-Q OptimizeRx Corp For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.37% | +2.48% | |
| Form 8-K OptimizeRx Corp For: Nov 06 | SEC filing · Form 8-K | SEC EDGAR | -10.72% | -14.81% | |
| OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance | Press release | GlobeNewswire | -10.72% | -14.81% | |
| OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET | Press release | GlobeNewswire | +0.51% | +2.89% | |
| OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference | Press release | GlobeNewswire | +1.07% | -0.90% | |
| OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising | Press release | GlobeNewswire | +1.07% | -0.90% | |
| Form 8-K OptimizeRx Corp For: Aug 15 | SEC filing · Form 8-K | SEC EDGAR | -1.03% | — | |
| OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth | Press release | GlobeNewswire | -1.03% | — | |
| Form 10-Q OptimizeRx Corp For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -6.57% | -6.47% | |
| Form 8-K OptimizeRx Corp For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +6.15% | +6.46% | |
| OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance | Press release | GlobeNewswire | +6.15% | +6.46% | |
| Paynela Appoints Healthcare Technology Veteran William Febbo to Board of Directors | Press release | Business Wire | — | -4.24% | |
| OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET | Press release | GlobeNewswire | +2.95% | -1.82% | |
| Form 8-K OptimizeRx Corp For: Jun 20 | SEC filing · Form 8-K | SEC EDGAR | -0.12% | -0.62% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the OPRX section they belong to.
Where else OPRX is measured.
OPRX earnings → · Analyst actions → · SEC filings →
Other Technology names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Rogers Corporation (ROG) | 278 | -0.10% | 42% |
| SPS Commerce, Inc. (SPSC) | 277 | 0.00% | 50% |
| MITSUBISHI ELEC UNSP/ADR (MIELY) | 275 | 0.00% | 48% |
| Evertec, Inc. (EVTC) | 274 | -0.10% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Technology names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is OptimizeRx Corporation's median reaction calculated?
Every labeled OPRX news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 276 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 46% of OPRX's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does OPRX's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.